It's been years since the major pharma companies agreed to participate in the Registry of All Trials, meaning that they'd end the practice of only reporting on trials whose outcomes they were pleased with, leaving about half of all trials unreported-on. (more…)
from Boing Boing http://ift.tt/2uBWB0X
via IFTTT
0 comments:
Post a Comment